Seeking for Investor for World's First Intranasal Vaccine Anti-Pneumonia for Sheep & Goat

Dear Sir,

INVITATION TO ACQUIRE EQUITY

With reference to the above matter, we are pleased to invite investors in our company.

Our major strength is through our product, which is an award-winning intranasal vaccine against Pneumonia Pasteurellosis for sheep and goats (small ruminants). It is the World’s first Intranasal Spray-based Anti-Pneumonia Vaccine for Sheep & Goats.

The potential market for the vaccine is huge, as evidenced by:

i Huge population of sheep and goats of 1.8 Billion heads
ii An average 5% – 10% annual growth rate in headcounts
iii Low product presence in Asia and Developing countries
iv Limited number of competitors
v Ineffectiveness of current vaccines and;
vi Relatively Low Cost of Protection against Mortality Value of Animals

As such, we have identified the novel competitive edge of the vaccine as follows:

i Proven effectiveness in reducing mortality rate to 10%, and
ii Novel Intranasal method

Please do not hesitate to contact us for any further details or discussions, and we hope for a positive response from your kind self.